Boston Tech Vertex Bought Crinetics for $10 Billion, Because Boston Enjoys Expensive Homework Vertex agreed to buy Crinetics for $10 billion on July 6, giving Boston biotech a huge endocrinology bet and a fresh test beyond cystic fibrosis.
